Delivery Order SPE2DB20D1100-SPE2DB25FD9S7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,501.05 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a $1,413.12 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack). This firm fixed-price contract, with an ultimate completion date of August 6, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award was competitively made with no set-aside designation, and performance will occur at the contractor's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order valued at $2,048.11 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (two-pack units). This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a competitively awarded contract with no set-aside designation. The supplies will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,425.21 for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) with a completion date of July 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a $1,795.27 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This firm fixed-price contract, with a completion date of August 12, 2025, represents a competitively awarded delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $1,987.16 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $1,874.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this delivery order, which falls under the...
- The Defense Logistics Agency awarded a delivery order valued at $2,363.20 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack configuration). This firm fixed-price delivery order, issued on July 21, 2025, with completion targeted for July 22, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was made without set-aside designation through open competition. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,237.60 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This firm fixed-price, competitively awarded delivery order was issued on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9S7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,920.12 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order under its existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. The delivery order represents a routine fulfillment of emergency medical supplies to support military healthcare operations. AmerisourceBergen's IDC with DLA enables the company to supply a broad range of pharmaceutical products and medical devices across multiple therapeutic domains to military and veteran healthcare systems worldwide. The contractor's extensive portfolio of federal awards and its status as a prime vendor under DLA's pharmaceutical supply chain demonstrate its established capability to meet urgent military medical supply requirements through efficient delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/11/25 |